Inhibition of rabbit platelet aggregation by the Ca2+-antagonists verapamil and diltiazem and by trifluoperazine
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 31 (4) , 565-576
- https://doi.org/10.1016/0049-3848(83)90454-1
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Requirement for different Ca2+ pools in the activation of rabbit plateletsII. Phospholipase activityBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- Requirements for different Ca2+ pools in the activation of rabbit plateletsI. Release reaction and protein phosphorylationBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- New total synthesis and high resolution 1H NMR spectrum of platelet-activating factor, its enantiomer and racemic mixturesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- EFFECTS OF VASODILATOR AGENTS ON SMOOTH MUSCLE CELLS OF THE CORONARY ARTERY OF THE PIGBritish Journal of Pharmacology, 1981
- Effects by nifedipine (Adalat®) on platelet function in vitro and in vivoThrombosis Research, 1981
- Platelet-Activating Factor (PAF-Acether) Secretion from Platelets: Effect of Aggregating AgentsBritish Journal of Haematology, 1980
- The Abilities of Human Blood Platelets to Bind Extracellular Calcium and to be Aggregated by Adenosine Diphosphate are RelatedBritish Journal of Haematology, 1980
- Calmodulin Plays a Pivotal Role in Cellular RegulationScience, 1980
- The role of platelet-activating factor in platelet aggregationNature, 1979
- Inhibition of platelet secretion by an antagonist of intracellular calciumBiochemical and Biophysical Research Communications, 1976